Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma
Clinical trial NCT03313206 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03313206
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2027-01-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.